Potential Utility of Urinary Follistatin as a Non-Invasive Indicator of Acute Tubular Damage in Patients with Acute Kidney Injury. | Potential Utility of Urinary Follistatin as a Non-Invasive Indicator of Acute Tubular Damage in Patients with Acute Kidney Injury. Nagayama I, Takayanagi K, Nagata D, Hasegawa H, Maeshima A., Free PMC Article | 03/29/2024 |
Elevated circulating follistatin associates with increased risk of mortality and cardiometabolic disorders. | Elevated circulating follistatin associates with increased risk of mortality and cardiometabolic disorders. Pan J, Nilsson J, Engström G, De Marinis Y. | 03/13/2024 |
Low follistatin level is a causal risk factor for spontaneous abortion: a two-sample mendelian randomization study. | Low follistatin level is a causal risk factor for spontaneous abortion: a two-sample mendelian randomization study. Gong C, Yang W, Liu X, Li X, Wang Y, Tian C., Free PMC Article | 01/30/2024 |
Follistatin and follistatin-like 3 in metabolic disorders. | Follistatin and follistatin-like 3 in metabolic disorders. Bielka W, Przezak A, Pawlik A. | 11/14/2023 |
Follistatin-controlled activin-HNF4alpha-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure. | Follistatin-controlled activin-HNF4α-coagulation factor axis in liver progenitor cells determines outcome of acute liver failure. Lin T, Wang S, Munker S, Jung K, Macías-Rodríguez RU, Ruiz-Margáin A, Schierwagen R, Liu H, Shao C, Fan C, Feng R, Yuan X, Wang S, Wandrer F, Meyer C, Wimmer R, Liebe R, Kroll J, Zhang L, Schiergens T, Ten Dijke P, Teufel A, Marx A, Mertens PR, Wang H, Ebert MPA, Bantel H, N De Toni E, Trebicka J, Dooley S, Shin D, Ding H, Weng HL. | 03/5/2022 |
Effects of Roux-en-Y gastric bypass on circulating follistatin, activin A, and peripheral ActRIIB signaling in humans with obesity and type 2 diabetes. | Effects of Roux-en-Y gastric bypass on circulating follistatin, activin A, and peripheral ActRIIB signaling in humans with obesity and type 2 diabetes. Pham TCP, Bojsen-Møller KN, Madsbad S, Wojtaszewski JFP, Richter EA, Sylow L. | 01/8/2022 |
Identification of frailty and sarcopenia in hospitalised older people. | Identification of frailty and sarcopenia in hospitalised older people. Echeverria I, Besga A, Sanz B, Amasene M, Hervás G, Barroso J, Rodriguez-Larrad A, Irazusta J. | 12/4/2021 |
Clinical relevance of circulating activin A and follistatin in small cell lung cancer. | Clinical relevance of circulating activin A and follistatin in small cell lung cancer. Barany N, Rozsas A, Megyesfalvi Z, Grusch M, Hegedus B, Lang C, Boettiger K, Schwendenwein A, Tisza A, Renyi-Vamos F, Schelch K, Hoetzenecker K, Hoda MA, Paku S, Laszlo V, Dome B. | 10/30/2021 |
Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans. | Serum Follistatin Is Increased in Thyroid Cancer and Is Associated With Adverse Tumor Characteristics in Humans. Panagiotou G, Ghaly W, Upadhyay J, Pazaitou-Panayiotou K, Mantzoros CS. | 10/2/2021 |
Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis. | Circulating resistin and follistatin levels in obese and non-obese women with polycystic ovary syndrome: A systematic review and meta-analysis. Raeisi T, Rezaie H, Darand M, Taheri A, Garousi N, Razi B, Roever L, Mohseni R, Hussien Mohammed S, Alizadeh S., Free PMC Article | 08/28/2021 |
The effects of concurrent training order on body composition and serum concentrations of follistatin, myostatin and GDF11 in sarcopenic elderly men. | The effects of concurrent training order on body composition and serum concentrations of follistatin, myostatin and GDF11 in sarcopenic elderly men. Bagheri R, Moghadam BH, Church DD, Tinsley GM, Eskandari M, Moghadam BH, Motevalli MS, Baker JS, Robergs RA, Wong A. | 05/8/2021 |
Regulatory aspects of myogenic factors GDF-8 and Follistatin on the intake of combined oral contraceptives. | Regulatory aspects of myogenic factors GDF-8 and Follistatin on the intake of combined oral contraceptives. Wallner C, Rausch A, Drysch M, Dadras M, Wagner JM, Becerikli M, Lehnhardt M, Behr B. | 02/13/2021 |
Follistatin impacts Tumor Angiogenesis and Outcome in Thymic Epithelial Tumors. | Follistatin impacts Tumor Angiogenesis and Outcome in Thymic Epithelial Tumors. Janik S, Bekos C, Hacker P, Raunegger T, Schiefer AI, Müllauer L, Veraar C, Dome B, Klepetko W, Ankersmit HJ, Moser B., Free PMC Article | 11/28/2020 |
Study presents evidence that Fst is a potent regulator of insulin action in muscle. Circulating Fst more than doubled post-Roux-en-Y gastric bypass surgery in obese patients, a treatment that markedly improved insulin sensitivity, suggesting a role for Fst in regulating glycaemic control. | Mechanisms involved in follistatin-induced hypertrophy and increased insulin action in skeletal muscle. Han X, Møller LLV, De Groote E, Bojsen-Møller KN, Davey J, Henríquez-Olguin C, Li Z, Knudsen JR, Jensen TE, Madsbad S, Gregorevic P, Richter EA, Sylow L., Free PMC Article | 08/1/2020 |
performances of serum activins and follistatin in the diagnosis of ectopic pregnancy: A prospective case-control study | The performances of serum activins and follistatin in the diagnosis of ectopic pregnancy: A prospective case-control study. Refaat B, Bahathiq AO. | 06/6/2020 |
Activin A even inhibits production and release of follistatin in RASF and therefore prevents itself from being blocked by its inhibitory binding protein follistatin in the local inflammatory joint environment. | The activin-follistatin anti-inflammatory cycle is deregulated in synovial fibroblasts. Diller M, Frommer K, Dankbar B, Tarner I, Hülser ML, Tsiklauri L, Hasseli R, Sauerbier M, Pap T, Rehart S, Müller-Ladner U, Neumann E., Free PMC Article | 05/30/2020 |
The aim of this study was to investigate the effect of FST gene on the inhibition of fibrosis in fibroblastic cells from scar tissue around repaired zone II flexor tendons. | Follistatin Mitigates Myofibroblast Differentiation and Collagen Synthesis of Fibroblasts from Scar Tissue around Injured Flexor Tendons. Kang YM, Lee SK, Chun YM, Choi YR, Moon SH, Lee HM, Kang HJ., Free PMC Article | 03/21/2020 |
Activin A (follicle-stimulating hormone-releasing protein inhibin beta A subunit inhibin beta A) signaling is restrained in normal mammary epithelia by concomitant inhibin alpha-subunit expression, and relatively higher levels of follistatin (FST) expression, however, these expression patterns are reversed in breast cancer [Review]. | The Activin Social Network: Activin, Inhibin, and Follistatin in Breast Development and Cancer. Seachrist DD, Keri RA., Free PMC Article | 12/21/2019 |
Fst is a pathological hepatokine that might be targeted for diabetes therapy during hepatic insulin resistance. | Inactivating hepatic follistatin alleviates hyperglycemia. Tao R, Wang C, Stöhr O, Qiu W, Hu Y, Miao J, Dong XC, Leng S, Stefater M, Stylopoulos N, Lin L, Copps KD, White MF., Free PMC Article | 05/11/2019 |
Circulating plasma follistatin and myostatin are negatively associated with muscle function in older women. | Relationship of muscle function to circulating myostatin, follistatin and GDF11 in older women and men. Fife E, Kostka J, Kroc Ł, Guligowska A, Pigłowska M, Sołtysik B, Kaufman-Szymczyk A, Fabianowska-Majewska K, Kostka T., Free PMC Article | 04/27/2019 |
these studies suggest that follistatin expression in invasive breast cancer is unrelated to the disease severity and the risk of recurrence, but is more intense in estrogen receptor -negative tumors | Follistatin Expression in Human Invasive Breast Tumors: Pathologic and Clinical Associations. Couto HL, Dela Cruz C, Buzelin MA, Toppa NH, Wainstein AJ, Reis FM. | 08/25/2018 |
Surface plasmon resonance analysis showed no significant association between FS288 and AMHC , suggesting that FS288 indirectly regulates AMH signaling. Activin A, a direct target of FS288, did not itself induce reporter activity in P19 cells, but did prevent the FS288-induced increase in AMH signaling. Hence, local concentrations of FS288 and Activin A may influence the response of some cell types to AMH. | Anti-Müllerian hormone signaling is influenced by Follistatin 288, but not 14 other transforming growth factor beta superfamily regulators. Kawagishi Y, Pankhurst MW, Nakatani Y, McLennan IS. | 04/14/2018 |
results suggest a role for FST as a suppressor of invasion and metastasis in breast cancer | Increased Expression of Follistatin in Breast Cancer Reduces Invasiveness and Clinically Correlates with Better Survival. Zabkiewicz C, Resaul J, Hargest R, Jiang WG, Ye L., Free PMC Article | 04/7/2018 |
These data indicate that FST is a bona fide metastasis suppressor in this mouse model and support future efforts to develop an FST mimetic to suppress metastatic progression. | Follistatin is a metastasis suppressor in a mouse model of HER2-positive breast cancer. Seachrist DD, Sizemore ST, Johnson E, Abdul-Karim FW, Weber Bonk KL, Keri RA., Free PMC Article | 03/31/2018 |
These findings indicate that muscle-specific Fst overexpression in pigs enhances skeletal muscle growth, at least partly due to myofiber hypertrophy and providing a promising approach to increase muscle mass in pigs and other livestock. | The transgenic expression of human follistatin-344 increases skeletal muscle mass in pigs. Chang F, Fang R, Wang M, Zhao X, Chang W, Zhang Z, Li N, Meng Q. | 01/6/2018 |